Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03672812Phase 3Completed
A Phase 3 trial of liraglutide in brain death, sponsored by Hospital de Clínicas de Porto Alegre. Started Sep 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03672812.